CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022
Reconciliation of net income to cash (used) provided by operating activities:
Net income	$ 14,564	$ 128,797
Add (deduct):
Depreciation and amortization	30,434	28,037
Adjustments for bad debt provisions	1,443	(157)
Net realized and unrealized losses	2,883	7,820
Amortization of net premium on debt securities investments	387	1,382
Payments for title losses (in excess of) less than provisions	(27,468)	16,902
Adjustments for insurance recoveries of title losses	0	220
(Increase) decrease in receivables – net	(6,692)	2,907
Increase in other assets – net	(5,859)	(6,720)
Decrease in accounts payable and other liabilities – net	(34,042)	(68,475)
Change in net deferred income taxes	585	515
Net income from equity method investments	(378)	(1,860)
Dividends received from equity method investments	876	2,150
Stock-based compensation expense	7,043	6,440
Other – net	269	229
Cash (used) provided by operating activities	(15,955)	118,187
Investing activities:
Proceeds from sales of investments in securities	39,488	28,769
Proceeds from matured investments in debt securities	55,250	23,521
Purchases of investments in securities	(55,461)	(117,913)
Net purchases of short-term investments	(2,838)	(189)
Purchases of property and equipment, and real estate	(15,495)	(26,226)
Proceeds from sale of property and equipment and other assets	106	1,033
Cash paid for acquisition of businesses	(22,400)	(23,310)
Increase in notes receivable	(6,360)	(3,667)
Other – net	400	6,840
Cash used by investing activities	(7,310)	(111,142)
Financing activities:
Proceeds from notes payable	3,538	5,721
Payments on notes payable	(5,776)	(44,553)
Distributions to noncontrolling interests	(7,549)	(9,483)
Repurchases of Common Stock	(1,353)	(2,551)
Proceeds from stock option and employee stock purchase plan exercises	1,991	2,713
Cash dividends paid	(24,531)	(20,258)
Payment of contingent consideration related to acquisitions	(2,000)	(15,997)
Other - net	0	94
Cash used by financing activities	(35,680)	(84,314)
Effects of changes in foreign currency exchange rates	617	(3,340)
Change in cash and cash equivalents	(58,328)	(80,609)
Cash and cash equivalents at beginning of period	248,367	485,919
Cash and cash equivalents at end of period	$ 190,039	$ 405,310